SCHEMBL802352

SCHEMBL802352

Cc1ccc2c(c1)S(=O)(=O)N(C)CCO2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 4/20 0.39
PIK3CB P42338 4/20 0.39
PIK3CG P48736 4/20 0.39
MAPT P10636 4/20 0.38
ALDH1A1 P00352 3/20 0.38
GAA P10253 1/20 0.38
HSD17B10 Q99714 1/20 0.38
KMT2A Q03164 3/20 0.38
PKM P14618 2/20 0.38
MEN1 O00255 1/20 0.38
RIPK1 Q13546 1/20 0.37
MMP12 P39900 1/20 0.36
PIK3CD O00329 2/20 0.36
THRB P10828 1/20 0.36
HTT P42858 2/20 0.35
LMNA P02545 1/20 0.35
TSHR P16473 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
CYP2C9 P11712 1/20 0.35
HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9697083 0.83 CA12 (0.44) MAPTALDH1A1GAAPKMPIK3CD
SCHEMBL25340956 0.83 LMNA (0.40) PIK3CAPIK3CBPIK3CGMAPTPIK3CD
SCHEMBL801403 0.83 DRD2 (0.43) MAPTALDH1A1HTTHPGD
SCHEMBL801936 0.80 HPGD (0.35) ALDH1A1GAAKMT2APKMMEN1
SCHEMBL24568190 0.79 KEAP1 (0.47) THRBHTTLMNATSHRRAB9A
SCHEMBL801940 0.76 GRIA2 (0.46) HSD17B10KMT2ALMNA
SCHEMBL25955579 0.76 LPL (0.33) ALDH1A1GAAHTT
SCHEMBL1777226 0.74 PIK3C3 (0.44) PIK3CAPIK3CBPIK3CGALDH1A1KMT2A
SCHEMBL27443955 0.73 ALDH1A1 (0.42) MAPTALDH1A1GAAHSD17B10KMT2A
SCHEMBL7602309 0.72 NOTUM (0.38) MAPTALDH1A1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8569285-B2 Dihydrobenzoxathiazepine compounds, a process for their preparation and pharmaceutical compositions containing them LES LABORATOIRES SERVIER (FR) 2013-10-29 US disclosed
US-20120071462-A1 Dihydrobenzoxathiazepine compounds, a process for their preparation and pharmaceutical compositions containing them LES LABORATOIRES SERVIER (FR) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071462-A1 Dihydrobenzoxathiazepine compounds, a process for their preparation and pharmaceutical compositions containing them GABRA1, GRM1, GABRA5 PIK3CA 1925/4885PIK3CB 1706/4885PIK3CG 2209/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.